Search
UV1
go.drugbank.com/drugs/DB18470ExperimentalUV1 is a cancer vaccine consisting of p719-20, p728, and p725 synthetic peptides representing fragments of the hTERT subunit
FCR001
go.drugbank.com/drugs/DB18595InvestigationalFCR001 is a somatic cell therapy product containing hematopoietic progenitor cells (HPC), Facilitating Cells (FC), and alpha beta T cells.
Leptazoline A
go.drugbank.com/drugs/DB15551ExperimentalLeptazoline A is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline B], [Leptazoline C], and [Leptazoline D].
Leptazoline B
go.drugbank.com/drugs/DB15552ExperimentalLeptazoline B is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline A], [Leptazoline C], and [Leptazoline D].
Leptazoline C
go.drugbank.com/drugs/DB15553ExperimentalLeptazoline C is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline A], [Leptazoline B], and [Leptazoline D].
SerpinPC
go.drugbank.com/drugs/DB17698InvestigationalSerpinPC is a mutated alpha-1-antitrypsin (α1AT) and serine protease inhibitor being investigated for the treatment of hemophilia.[A258993]